Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...

The latest announcement is out from Solasia Pharma KK ( (JP:4597) ).

Pfizer said revenue should come in at the lower end of its guidance for this year, while it expects less revenue in 2026 than in 2025, as the drugmaker’s efforts to remake its business continue to ...

According to MarketsandMarkets, the report "Flexible Plastic Bags Packaging Market by Application (Food, Beverages, ...

With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion. The midpoint of the projection ($61 billion) ...

FORECAST.ETS applies an exponential triple smoothing (ETS) algorithm to create forecasts that can include trend and seasonal ...

Specialty drugs surpass pharma sales, reaching 52% of U.S. pharmaceutical sales in 2024, driven by immunology and oncology therapies.

Shares of Globus Medical rose after the company issued preliminary fourth-quarter sales numbers and a 2026 outlook that both beat analysts' expectations. The stock gained 10% to $99.74 in after-hours ...

CGTN Europe interviewed Matt Maley, Chief Market Strategist, Miller Tabak + Co., LLC Morrisons loses £17m court battle over rotisserie chicken Ukraine-Russia war latest: Moscow refuses to give up land ...

GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the ...

The market underappreciates TENX's late-stage pipeline and risk-adjusted asset value; we recommend buying ahead of Phase 3 ...